文献速递胸部技术与安全US

疑似COVID-19住院患者肺部床旁超声评估的前瞻性队列研究

Lung Assessment with Point-of-Care Ultrasound in Respiratory Coronavirus Disease (COVID-19): A Prospective Cohort Study.
PubMed 文献 · Ultrasound Med Biol · 2020-12-26

在瑞士一家三级医疗中心开展前瞻性队列研究,对疑似COVID-19住院患者采用12区肺部超声方案扫描,以最终诊断为标准评估诊断准确性。49例中11例(22%)最终确诊COVID-19,总分0-36分与最终诊断相关,每增加1分OR为1.30(95%CI 1.09-1.54,P=0.003),AUC为0.85(95%CI 0.71-0.99);以8/36分为界值,敏感度91%(95%CI 59%-100%),特异度76%(95%CI 60%-89%)。

要点

  • 肺部超声总分与COVID-19最终诊断独立相关:每增加1分OR为1.30(95%CI 1.09-1.54)。
  • 总分AUC为0.85(95%CI 0.71-0.99),对疑似COVID-19住院患者有较好判别能力。
  • 以8/36分为界值,敏感度91%、特异度76%,各有10/11和29/38例被正确分类。

核心结论

  • 肺部超声对疑似COVID-19住院患者显示出有希望的判别潜力。

研究设计与样本

  • 前瞻性队列研究,在瑞士一家三级医疗中心纳入疑似COVID-19住院患者共49例。
  • 采用12区肺部超声方案扫描,计算0-36分总分,以最终诊断作为参考标准。
  • 采用ROC曲线下面积及不同界值的敏感度和特异度分析总分与最终诊断的关联。

关键影像表现/征象

  • 原文未报告具体肺部超声征象描述。

诊断标准与关键数值

  • 总分每增加1分OR为1.30(95%CI 1.09-1.54,P=0.003)。
  • 总分AUC为0.85(95%CI 0.71-0.99)。
  • 以8/36分为界值,敏感度91%(95%CI 59%-100%),特异度76%(95%CI 60%-89%)。
  • 8/36分界值时,11例最终确诊COVID-19者中10例被正确预测,38例未确诊者中29例被正确排除。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原始摘要未明确报告局限性,仅提到肺部超声在疑似COVID-19住院患者中显示出有希望的判别潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Lung ultrasound (LUS) has shown promising diagnostic potential in different pulmonary conditions. We evaluated the diagnostic accuracy of LUS for pulmonary COVID-19. In this prospective cohort study at a Swiss tertiary care center, patients hospitalized with suspected COVID-19 were scanned using a 12-zone protocol. Association of a summation score (0-36 points) with the final diagnosis was tested using the area under the receiver operating characteristic curve and sensitivity and specificity at different cutoff points. Of the 49 participants, 11 (22%) were later diagnosed with COVID-19. LUS score showed excellent diagnostic performance, with an odds ratio of 1.30 per point (95% confidence interval [CI], 1.09-1.54, p = 0.003) and an area under the curve of 0.85 (95% CI, 0.71-0.99). At a cutoff of 8/36 points, 10 of 11 participants later diagnosed with COVID-19 were correctly predicted (sensitivity 91%, 95% CI, 59%-100%), and 29 of the 38 who were not diagnosed with COVID-19 were correctly ruled out (specificity 76%, 95% CI, 60%-89%). LUS demonstrated promising discriminatory potential in people hospitalized with suspected COVID-19.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Speidel V, Conen A, Gisler V, et al. Lung Assessment with Point-of-Care Ultrasound in Respiratory Coronavirus Disease (COVID-19): A Prospective Cohort Study. Ultrasound Med Biol. 2020. PMID: 33487473. doi:10.1016/j.ultrasmedbio.2020.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。